US$ 27.57
mb glp 1 GLP-1 and the New Consumer Economy- The VAAN® Group Lifevantage Protandim and : Livevantage
Description
November 2023 : Eli Lilly received US FDA approval for ZEPBOUND, an obesity treatment that activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors

Studies suggest it modulates neurotransmitters like serotonin and dopamine, which are essential for emotional regulation

Results from preclinical studies indicate that endogenous and exogenous GLP-1 reduces dopamine in synapses and promotes the potentiation of GABAergic neurotransmitter release via MHb-IPN circuits, attenuating the reinforcing properties of nicotine [22]

Injection site options include: - Back of arm - Belly (stay more than 1-2 inches AWAY from belly button) - Fatty part of thigh Administer the Injection: Most patients feel more comfort pinching the injection site for this step

N Engl J Med 377:839848 Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR et al (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
